Literature DB >> 12430672

Transmission of Babesia microti in Minnesota through four blood donations from the same donor over a 6-month period.

Barbara L Herwaldt1, David F Neitzel, Jed B Gorlin, Kathryn A Jensen, Elizabeth H Perry, William R Peglow, Susan B Slemenda, Kimberly Y Won, Eva K Nace, Norman J Pieniazek, Marianna Wilson.   

Abstract

BACKGROUND: Babesiosis is a tick-borne zoonosis caused by intraerythrocytic protozoa. More than 40 US cases of Babesia microti infection acquired by blood transfusion have been reported. This report describes the identification of a transfusion-associated case of babesiosis and the subsequent identification of the infected blood donor and three other infected recipients of cellular blood components from three other donations by this donor. STUDY DESIGN AND METHODS: Serum specimens from the donors of blood that had been made into cellular components received by the index recipient and from other recipients of such components from the implicated donor were tested by the indirect fluorescent antibody (IFA) assay for antibodies to B. microti. Whole blood from IFA-positive persons was tested by PCR for B. microti DNA.
RESULTS: IFA testing of serum from 31 of 36 donors implicated a 45-year-old man (titer, 1 in 256), whose donation had been used for RBCs. He likely became infected when bitten by ticks while camping in Minnesota in June 1999 and had donated blood four times thereafter. As demonstrated by PCR, he remained parasitemic for at least 10 months. Of the five other surviving recipients of cellular blood components from the implicated donor, three recipients (one for each of the three other donations) had become infected through either RBC or platelet transfusions.
CONCLUSIONS: Babesiosis should be included in the differential diagnosis of posttransfusion febrile illness, and effective means for preventing transmission by blood transfusion are needed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12430672     DOI: 10.1046/j.1537-2995.2002.00189.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  14 in total

1.  Arboprotozoae.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

2.  Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.

Authors:  Marcie Tomblyn; Tom Chiller; Hermann Einsele; Ronald Gress; Kent Sepkowitz; Jan Storek; John R Wingard; Jo-Anne H Young; Michael J Boeckh; Michael A Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2009-10       Impact factor: 5.742

3.  A longitudinal study of Babesia microti infection in seropositive blood donors.

Authors:  David A Leiby; Stephanie T Johnson; Kimberly Y Won; Eva K Nace; Susan B Slemenda; Norman J Pieniazek; Ritchard G Cable; Barbara L Herwaldt
Journal:  Transfusion       Date:  2014-03-28       Impact factor: 3.157

4.  Serological diagnosis of human babesiosis by IgG enzyme-linked immunosorbent assay.

Authors:  Chien Chang Loa; Martin E Adelson; Eli Mordechai; Israel Raphaelli; Richard C Tilton
Journal:  Curr Microbiol       Date:  2004-12       Impact factor: 2.188

Review 5.  Human babesiosis.

Authors:  Edouard Vannier; Benjamin E Gewurz; Peter J Krause
Journal:  Infect Dis Clin North Am       Date:  2008-09       Impact factor: 5.982

6.  Multiplex assay detection of immunoglobulin G antibodies that recognize Babesia microti antigens.

Authors:  Jeffrey W Priest; Delynn M Moss; Kimberly Won; Charles W Todd; Leslie Henderson; Cara C Jones; Marianna Wilson
Journal:  Clin Vaccine Immunol       Date:  2012-08-01

7.  Sensitive multiplex PCR assay to differentiate Lyme spirochetes and emerging pathogens Anaplasma phagocytophilum and Babesia microti.

Authors:  Kamfai Chan; Salvatore A E Marras; Nikhat Parveen
Journal:  BMC Microbiol       Date:  2013-12-20       Impact factor: 3.605

8.  Babesia infection in the southwest of china, a case report.

Authors:  Huixuan Wang; Fen Huang
Journal:  Jundishapur J Microbiol       Date:  2014-11-01       Impact factor: 0.747

9.  Cost implications of implementation of pathogen-inactivated platelets.

Authors:  Jeffrey McCullough; Dennis Goldfinger; Jed Gorlin; William J Riley; Harpreet Sandhu; Christopher Stowell; Dawn Ward; Mary Clay; Shelley Pulkrabek; Vera Chrebtow; Adonis Stassinopoulos
Journal:  Transfusion       Date:  2015-05-18       Impact factor: 3.157

10.  Chapter 4: Red cell transfusion to treat anemia in CKD.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2012-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.